Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil
Clinical trial NCT05256537 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05256537
- Sponsor
- Ronald Paquette
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2024-09-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.